$FPAY
FlexShopper, Inc. Stock $fpay

$fpay Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023066993 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q4
Revenue	$31.39M	$24.53M	$21.41M
YoY Change	20.06%	-32.88%	-31.14%
Cost Of Revenue	$14.45M	$16.14M	$17.57M
YoY Change	-22.91%	-11.35%	-6.93%
Gross Profit	$16.94M	$8.391M	$3.843M
YoY Change	129.03%	-54.25%	-68.55%
Gross Profit Margin	53.96%	34.21%	17.95%
Selling, General & Admin	$5.878M	$5.230M	$5.537M
YoY Change	6.92%	-28.16%	-17.58%
% of Gross Profit	34.71%	62.33%	144.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.271M	$1.207M	$1.466M
YoY Change	17.57%	7.63%	-92.06%
% of Gross Profit	7.51%	14.38%	38.15%
Operating Expenses	$10.98M	$26.56M	$26.89M
YoY Change	-8.04%	99.15%	137.31%
Operating Profit	$5.952M	-$2.031M	-$23.04M
YoY Change	-230.86%	-140.61%	-2695.85%
Interest Expense	$4.747M	$4.569M	-$3.825M
YoY Change	56.65%	94.59%	176.49%
% of Operating Profit	79.75%
Other Income/Expense, Net
YoY Change
Pretax Income	$1.206M	-$6.600M	$5.161M
YoY Change	-115.91%	-348.61%	-1140.93%
Income Tax	$265.5K	-$1.302M	-$2.743M
% Of Pretax Income	22.02%		-53.14%
Net Earnings	$940.1K	-$5.298M	$5.941M
YoY Change	-114.97%	-136.82%	838.05%
Net Earnings / Revenue	3.0%	-21.59%	27.75%
Basic Earnings Per Share	-$0.01	-$0.22
Diluted Earnings Per Share	-$0.01	-$0.22	$0.26
COMMON SHARES
Basic Shares Outstanding	21.75M shares	21.75M shares	21.75M shares
Diluted Shares Outstanding	21.72M shares	28.92M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.732M	$6.373M	$6.052M
YoY Change	8.69%	27.75%	18.79%
Cash & Equivalents	$5.732M	$6.373M	$6.052M
Short-Term Investments
Other Short-Term Assets	$26.44M	$27.67M	$35.16M
YoY Change	-18.92%	-26.62%	-16.08%
Inventory
Prepaid Expenses		$3.069M	$3.489M
Receivables	$41.42M	$39.23M	$35.54M
Other Receivables
Total Short-Term Assets	$105.3M	$98.38M	$109.7M
YoY Change	7.53%	0.09%	42.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.011M	$8.831M	$8.087M
YoY Change	21.5%	-6.05%	3.13%
Goodwill
YoY Change
Intangibles	$13.83M	$14.28M	$15.16M
YoY Change			305592.52%
Long-Term Investments
YoY Change
Other Assets	$15.02M	$15.30M	$13.95M
YoY Change	-2.08%	24.22%	17879.58%
Total Long-Term Assets	$39.14M	$39.74M	$38.60M
YoY Change	61.77%	82.95%	387.5%
TOTAL ASSETS
Total Short-Term Assets	$105.3M	$98.38M	$109.7M
Total Long-Term Assets	$39.14M	$39.74M	$38.60M
Total Assets	$144.4M	$138.1M	$148.3M
YoY Change	18.28%	15.09%	74.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.011M	$4.005M	$6.512M
YoY Change	3.49%	-23.6%	-18.42%
Accrued Expenses	$2.835M	$2.387M	$3.988M
YoY Change	-12.6%	-50.04%	33.49%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$421.8K	$1.427M	$1.409M
YoY Change	-64.59%	21.31%	32.69%
Total Short-Term Liabilities	$7.878M	$8.128M	$12.23M
YoY Change	-14.41%	-31.09%	-2.85%
LONG-TERM LIABILITIES
Long-Term Debt	$106.6M	$101.2M	$94.76M
YoY Change	21.05%	30.62%	76.05%
Other Long-Term Liabilities	$1.387M	$1.448M	$10.27M
YoY Change	678.38%	712.63%	1973.19%
Total Long-Term Liabilities	$107.9M	$102.7M	$105.0M
YoY Change	60484.46%	57542.54%	21110.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.878M	$8.128M	$12.23M
Total Long-Term Liabilities	$107.9M	$102.7M	$105.0M
Total Liabilities	$115.8M	$110.8M	$117.3M
YoY Change	16.96%	21.58%	70.76%
SHAREHOLDERS EQUITY
Retained Earnings	-$36.18M	-$37.12M	-$31.59M
YoY Change	-8.4%	11.76%	-30.14%
Common Stock	$2.176K	$2.176K	$2.176K
YoY Change	0.0%	0.69%	1.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$100.2K
YoY Change
Treasury Stock Shares
Shareholders Equity	$28.60M	$27.29M	$31.03M
YoY Change
Total Liabilities & Shareholders Equity	$144.4M	$138.1M	$148.3M
YoY Change	18.28%	15.09%	74.84%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q4
OPERATING ACTIVITIES
Net Income	$940.1K	-$5.298M	$5.941M
YoY Change	-114.97%	-136.82%	838.05%
Depreciation, Depletion And Amortization	$1.271M	$1.207M	$1.466M
YoY Change	17.57%	7.63%	-92.06%
Cash From Operating Activities	-$2.907M	-$128.3K	-$3.691M
YoY Change	-63.08%	-98.91%	-70.27%
INVESTING ACTIVITIES
Capital Expenditures	$1.677M	$1.535M	$2.063M
YoY Change	-170.19%	-171.95%	-238.45%
Acquisitions
YoY Change
Other Investing Activities			$2.938M
YoY Change
Cash From Investing Activities	-$1.677M	-$1.535M	$875.2K
YoY Change	-29.81%	-28.05%	-158.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.948M	-1.827M	3.234M
YoY Change	-62.64%	-112.19%	-79.6%
NET CHANGE
Cash From Operating Activities	-2.907M	-128.3K	-3.691M
Cash From Investing Activities	-1.677M	-1.535M	875.2K
Cash From Financing Activities	3.948M	-1.827M	3.234M
Net Change In Cash	-635.5K	-3.491M	417.2K
YoY Change	-307.6%	-408.83%	-78.57%
FREE CASH FLOW
Cash From Operating Activities	-$2.907M	-$128.3K	-$3.691M
Capital Expenditures	$1.677M	$1.535M	$2.063M
Free Cash Flow	-$4.584M	-$1.663M	-$5.755M
YoY Change	-16.44%	-82.67%	-47.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-37945
	dei	Entity Registrant Name EntityRegistrantName	FLEXSHOPPER, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-5456087
	dei	Entity Address Address Line1 EntityAddressAddressLine1	901 Yamato Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 260
	dei	Entity Address City Or Town EntityAddressCityOrTown	Boca Raton
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33431
	dei	City Area Code CityAreaCode	(855)
	dei	Local Phone Number LocalPhoneNumber	353-9289
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	FPAY
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21752304	shares
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	6372699	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	6051713	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	6285	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	121636	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39227399	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35540043	usd
CY2023Q2	us-gaap	Securities Received As Collateral SecuritiesReceivedAsCollateral	25105046	usd
CY2022Q4	us-gaap	Securities Received As Collateral SecuritiesReceivedAsCollateral	32932504	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3068559	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3489136	usd
CY2023Q2	fpay	Lease Merchandise LeaseMerchandise	24597836	usd
CY2022Q4	fpay	Lease Merchandise LeaseMerchandise	31550441	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	98377824	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	109685473	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8830978	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8086862	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1324953	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1406270	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	14276231	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15162349	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	1832175	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	1934728	usd
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	13471568	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	12013828	usd
CY2023Q2	us-gaap	Assets Assets	138113729	usd
CY2022Q4	us-gaap	Assets Assets	148289510	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	4005219	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6511943	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	299741	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	310820	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	1207798	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1209455	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2386547	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3988093	usd
CY2023Q2	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	228358	usd
CY2022Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	208001	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	8127663	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12228312	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	211516	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	352252	usd
CY2023Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	80943484	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	80847748	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Premium Noncurrent DebtInstrumentUnamortizedPremiumNoncurrent	879348	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Premium Noncurrent DebtInstrumentUnamortizedPremiumNoncurrent	0	usd
CY2023Q2	fpay	Promissory Notes To Related Parties Net Of Current Portion PromissoryNotesToRelatedPartiesNetOfCurrentPortion	9870652	usd
CY2022Q4	fpay	Promissory Notes To Related Parties Net Of Current Portion PromissoryNotesToRelatedPartiesNetOfCurrentPortion	10750000	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	1046551	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	1165027	usd
CY2023Q2	fpay	Promissory Note Related To Acquisition1 PromissoryNoteRelatedToAcquisition1	3133617	usd
CY2022Q4	fpay	Promissory Note Related To Acquisition1 PromissoryNoteRelatedToAcquisition1	3158471	usd
CY2023Q2	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	112197	usd
CY2023Q2	us-gaap	Notes And Loans Payable NotesAndLoansPayable	7300408	usd
CY2022Q4	us-gaap	Other Notes Payable OtherNotesPayable	8703684	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1447788	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1566622	usd
CY2023Q2	us-gaap	Liabilities Liabilities	110823612	usd
CY2022Q4	us-gaap	Liabilities Liabilities	117254837	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21752304	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21752304	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21750804	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21750804	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	2176	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2176	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	41602734	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	39819420	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37118453	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31590583	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	27290117	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	31034673	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	138113729	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	148289510	usd
CY2023Q2	fpay	Lease Revenues And Fees Net LeaseRevenuesAndFeesNet	22906843	usd
CY2022Q2	fpay	Lease Revenues And Fees Net LeaseRevenuesAndFeesNet	30468476	usd
	fpay	Lease Revenues And Fees Net LeaseRevenuesAndFeesNet	47621001	usd
	fpay	Lease Revenues And Fees Net LeaseRevenuesAndFeesNet	58234788	usd
CY2023Q2	fpay	Net Changes In The Fair Value Of Loans Receivable At Fair Value Amount NetChangesInTheFairValueOfLoansReceivableAtFairValueAmount	1625193	usd
CY2022Q2	fpay	Net Changes In The Fair Value Of Loans Receivable At Fair Value Amount NetChangesInTheFairValueOfLoansReceivableAtFairValueAmount	6079675	usd
	fpay	Net Changes In The Fair Value Of Loans Receivable At Fair Value Amount NetChangesInTheFairValueOfLoansReceivableAtFairValueAmount	7696810	usd
	fpay	Net Changes In The Fair Value Of Loans Receivable At Fair Value Amount NetChangesInTheFairValueOfLoansReceivableAtFairValueAmount	7268599	usd
CY2023Q2	us-gaap	Revenues Revenues	24532036	usd
CY2022Q2	us-gaap	Revenues Revenues	36548151	usd
	us-gaap	Revenues Revenues	55317811	usd
	us-gaap	Revenues Revenues	65503387	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	14485417	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18207305	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	29831205	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	37367916	usd
CY2023Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1655424	usd
CY2022Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	804228	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	3489051	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1229741	usd
CY2023Q2	us-gaap	Marketing Expense MarketingExpense	1488578	usd
CY2022Q2	us-gaap	Marketing Expense MarketingExpense	3770820	usd
	us-gaap	Marketing Expense MarketingExpense	2587767	usd
	us-gaap	Marketing Expense MarketingExpense	5784935	usd
CY2023Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2976008	usd
CY2022Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3014920	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5702898	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	5979362	usd
CY2023Q2	us-gaap	Other General Expense OtherGeneralExpense	5957932	usd
CY2022Q2	us-gaap	Other General Expense OtherGeneralExpense	5748286	usd
	us-gaap	Other General Expense OtherGeneralExpense	11585640	usd
	us-gaap	Other General Expense OtherGeneralExpense	11421488	usd
CY2023Q2	us-gaap	Costs And Expenses CostsAndExpenses	26563359	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	31545559	usd
	us-gaap	Costs And Expenses CostsAndExpenses	53196561	usd
	us-gaap	Costs And Expenses CostsAndExpenses	61783442	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2031323	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	5002592	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2121250	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	3719945	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	4568557	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	2347838	usd
	us-gaap	Interest Expense InterestExpense	9099884	usd
	us-gaap	Interest Expense InterestExpense	4305906	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6599880	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2654754	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6978634	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-585961	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1302225	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11734467	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1450764	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-12594247	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-5297655	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	14389221	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5527870	usd
	us-gaap	Net Income Loss NetIncomeLoss	12008286	usd
CY2023Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	992493	usd
CY2022Q2	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	609777	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1964726	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1219554	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6290148	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	13779444	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7492596	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	10788732	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.49
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.51
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28923393	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21605234	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21751807	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21576312	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28923393	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27898824	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21751807	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28193268	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	31034673	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	420748	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1185	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-230215	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	31226391	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	443800	usd
CY2023Q2	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	917581	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-5297655	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	27290117	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16143619	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	305229	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	137057	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2380935	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	14204970	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	257476	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	14389221	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	28851667	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5527870	usd
	us-gaap	Net Income Loss NetIncomeLoss	12008286	usd
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	29831205	usd
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	37367916	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	3710703	usd
	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	2059323	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	182174	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	106886	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	118476	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	864548	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	562705	usd
	fpay	Provisions For Doubtful Accounts ProvisionsForDoubtfulAccounts	-22085828	usd
	fpay	Provisions For Doubtful Accounts ProvisionsForDoubtfulAccounts	-27563993	usd
	fpay	Interest In Kind Added To Promissory Notes Balance InterestInKindAddedToPromissoryNotesBalance	113509	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1457740	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-12561074	usd
	fpay	Net Changes In The Fair Value Of Loans Receivable At Fair Value NetChangesInTheFairValueOfLoansReceivableAtFairValue	837048	usd
	fpay	Net Changes In The Fair Value Of Loans Receivable At Fair Value NetChangesInTheFairValueOfLoansReceivableAtFairValue	-2457851	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	25773184	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	34275950	usd
	fpay	Increase Decrease In Loans Receivable At Fair Value IncreaseDecreaseInLoansReceivableAtFairValue	-6990410	usd
	fpay	Increase Decrease In Loans Receivable At Fair Value IncreaseDecreaseInLoansReceivableAtFairValue	16516074	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-412391	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	155773	usd
	fpay	Increase Decrease In Lease Liability IncreaseDecreaseInLeaseLiability	22878600	usd
	fpay	Increase Decrease In Lease Liability IncreaseDecreaseInLeaseLiability	32562799	usd
	fpay	Purchase Consideration Payable Related To Acquisition PurchaseConsiderationPayableRelatedToAcquisition	208921	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-12243	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5091	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2506724	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2740017	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-11079	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	25656	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1603202	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1794983	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5471062	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19671372	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3114534	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2924537	usd
	fpay	Purchases Of Data Costs PurchasesOfDataCosts	343428	usd
	fpay	Purchases Of Data Costs PurchasesOfDataCosts	762704	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3457962	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3687241	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	2750000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	17800000	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	2795000	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	1125000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1500000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	115403	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	86932	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1185	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	137057	usd
	fpay	Proceeds From Debt Instrument ProceedsFromDebtInstrument	7000000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	4917	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	5592	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	143330	usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	5605	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1807465	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	23713928	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	205635	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	355315	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6173349	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5094642	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6378984	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5449957	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	8453511	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3953765	usd
	fpay	Due Date Extension Of Warrants DueDateExtensionOfWarrants	917581	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Estimates -</b> The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p>
CY2022Q2	fpay	Accounts Receivable Charged Off Against Allowance AccountsReceivableChargedOffAgainstAllowance	23719531	usd
	fpay	Accounts Receivable Charged Off Against Allowance AccountsReceivableChargedOffAgainstAllowance	40803098	usd
CY2023Q2	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	1252600	usd
	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	837048	usd
CY2022Q2	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	2981275	usd
	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	2457851	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6372699	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6051713	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	6285	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	121636	usd
CY2023Q2	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	6378984	usd
CY2022Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	6173349	usd
CY2023Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	41663220	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	48618843	usd
CY2023Q2	fpay	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	2435821	usd
CY2022Q4	fpay	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	13078800	usd
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	39227399	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	35540043	usd
CY2023Q2	fpay	Accounts Receivable Charged Off Against Allowance AccountsReceivableChargedOffAgainstAllowance	13757036	usd
	fpay	Accounts Receivable Charged Off Against Allowance AccountsReceivableChargedOffAgainstAllowance	32728807	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13078800	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	27703278	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	22085828	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	57420480	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	32728807	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	72044958	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2435821	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13078800	usd
CY2023Q2	fpay	Lease Merchandise At Cost LeaseMerchandiseAtCost	52734813	usd
CY2022Q4	fpay	Lease Merchandise At Cost LeaseMerchandiseAtCost	62379920	usd
CY2023Q2	fpay	Impairment Reserve ImpairmentReserve	28136977	usd
CY2022Q4	fpay	Impairment Reserve ImpairmentReserve	30829479	usd
CY2023Q2	fpay	Lease Merchandise Net LeaseMerchandiseNet	24597836	usd
CY2022Q4	fpay	Lease Merchandise Net LeaseMerchandiseNet	31550441	usd
CY2023Q2	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	32501656	usd
CY2022Q2	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	39596845	usd
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	66756740	usd
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	79194274	usd
CY2023Q2	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	10847413	usd
CY2022Q2	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	15732876	usd
	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	22085828	usd
	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	27563993	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	1252600	usd
CY2022Q2	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	6604507	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	2950089	usd
	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	6604507	usd
CY2023Q2	fpay	Lease Revenues And Fees LeaseRevenuesAndFees	22906843	usd
CY2022Q2	fpay	Lease Revenues And Fees LeaseRevenuesAndFees	30468476	usd
	fpay	Lease Revenues And Fees LeaseRevenuesAndFees	47621001	usd
	fpay	Lease Revenues And Fees LeaseRevenuesAndFees	58234788	usd
CY2023Q2	fpay	Interest Expense Debt Including Amortization InterestExpenseDebtIncludingAmortization	3206	usd
	fpay	Interest Expense Debt Including Amortization InterestExpenseDebtIncludingAmortization	3206	usd
CY2023Q2	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	443059	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	886118	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	769	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1538	usd
CY2023Q2	us-gaap	Payments For Software PaymentsForSoftware	1227024	usd
	us-gaap	Payments For Software PaymentsForSoftware	2522838	usd
CY2022Q2	us-gaap	Payments For Software PaymentsForSoftware	1285088	usd
	us-gaap	Payments For Software PaymentsForSoftware	2270082	usd
CY2023Q2	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	961061	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1870405	usd
CY2022Q2	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	683161	usd
	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	1304855	usd
CY2023Q2	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	174346	usd
	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	343428	usd
CY2022Q2	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	469650	usd
	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	762704	usd
CY2023Q2	fpay	Capitalized Data Costs Amortization Expense CapitalizedDataCostsAmortizationExpense	234417	usd
	fpay	Capitalized Data Costs Amortization Expense CapitalizedDataCostsAmortizationExpense	454167	usd
CY2022Q2	fpay	Capitalized Data Costs Amortization Expense CapitalizedDataCostsAmortizationExpense	120938	usd
	fpay	Capitalized Data Costs Amortization Expense CapitalizedDataCostsAmortizationExpense	209659	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15011682	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13169423	shares
	fpay	Net Incomelosses NetIncomelosses	-5527870	usd
	fpay	Net Incomelosses NetIncomelosses	12008286	usd
	fpay	Convertible Series2 Preferred Share Dividends ConvertibleSeries2PreferredShareDividends	-1964726	usd
	fpay	Convertible Series2 Preferred Share Dividends ConvertibleSeries2PreferredShareDividends	-1219554	usd
	fpay	Net Incomeloss Attributable To Common And Series1 Convertible Preferred Stock NetIncomelossAttributableToCommonAndSeries1ConvertiblePreferredStock	-7492596	usd
	fpay	Net Incomeloss Attributable To Common And Series1 Convertible Preferred Stock NetIncomelossAttributableToCommonAndSeries1ConvertiblePreferredStock	10788732	usd
	fpay	Net Income Attributable To Series1 Convertible Preferred Stock NetIncomeAttributableToSeries1ConvertiblePreferredStock	-124057	usd
	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	12599	usd
	fpay	Net Incomeloss Attributable To Common Shares Numerator For Basic Eps NetIncomelossAttributableToCommonSharesNumeratorForBasicEPS	-7492596	usd
	fpay	Net Incomeloss Attributable To Common Shares Numerator For Basic Eps NetIncomelossAttributableToCommonSharesNumeratorForBasicEPS	10677274	usd
	fpay	Convertible Preferred Stock Dividends ConvertiblePreferredStockDividends	1219554	usd
	fpay	Net Incomeloss Attributable To Common Shares After Assumed Conversions Numerator For Diluted Eps NetIncomelossAttributableToCommonSharesAfterAssumedConversionsNumeratorForDilutedEps	-7492596	usd
	fpay	Net Incomeloss Attributable To Common Shares After Assumed Conversions Numerator For Diluted Eps NetIncomelossAttributableToCommonSharesAfterAssumedConversionsNumeratorForDilutedEps	11896828	usd
	fpay	Weighted Average Of Common Shares Outstanding Denominator For Basic Ep Sin Shares WeightedAverageOfCommonSharesOutstandingDenominatorForBasicEPSinShares	21751807	shares
	fpay	Weighted Average Of Common Shares Outstanding Denominator For Basic Ep Sin Shares WeightedAverageOfCommonSharesOutstandingDenominatorForBasicEPSinShares	21576312	shares
	fpay	Series2 Convertible Preferred Stockin Shares Series2ConvertiblePreferredStockinShares	5845695	shares
	fpay	Series1 Convertible Preferred Stockin Shares Series1ConvertiblePreferredStockinShares	225231	shares
	fpay	Common Stock Options And Performance Share Unitsin Shares CommonStockOptionsAndPerformanceShareUnitsinShares	355753	shares
	fpay	Common Stock Warrants CommonStockWarrants	190277	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	21751807	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	28193268	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.49
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2023Q2	fpay	Net Incomelosses NetIncomelosses	-5297655	usd
CY2022Q2	fpay	Net Incomelosses NetIncomelosses	14389221	usd
CY2023Q2	fpay	Convertible Series2 Preferred Share Dividends ConvertibleSeries2PreferredShareDividends	-992493	usd
CY2022Q2	fpay	Convertible Series2 Preferred Share Dividends ConvertibleSeries2PreferredShareDividends	-609777	usd
CY2023Q2	fpay	Net Incomeloss Attributable To Common And Series1 Convertible Preferred Stock NetIncomelossAttributableToCommonAndSeries1ConvertiblePreferredStock	-6290148	usd
CY2022Q2	fpay	Net Incomeloss Attributable To Common And Series1 Convertible Preferred Stock NetIncomelossAttributableToCommonAndSeries1ConvertiblePreferredStock	13779444	usd
CY2022Q2	fpay	Net Income Attributable To Series1 Convertible Preferred Stock NetIncomeAttributableToSeries1ConvertiblePreferredStock	-148457	usd
CY2022Q2	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	6291	usd
CY2023Q2	fpay	Net Incomeloss Attributable To Common Shares Numerator For Basic Eps NetIncomelossAttributableToCommonSharesNumeratorForBasicEPS	-6290148	usd
CY2022Q2	fpay	Net Incomeloss Attributable To Common Shares Numerator For Basic Eps NetIncomelossAttributableToCommonSharesNumeratorForBasicEPS	13637278	usd
CY2022Q2	fpay	Convertible Preferred Stock Dividends ConvertiblePreferredStockDividends	609777	usd
CY2023Q2	fpay	Net Incomeloss Attributable To Common Shares After Assumed Conversions Numerator For Diluted Eps NetIncomelossAttributableToCommonSharesAfterAssumedConversionsNumeratorForDilutedEps	-6290148	usd
CY2022Q2	fpay	Net Incomeloss Attributable To Common Shares After Assumed Conversions Numerator For Diluted Eps NetIncomelossAttributableToCommonSharesAfterAssumedConversionsNumeratorForDilutedEps	14247055	usd
CY2023Q2	fpay	Weighted Average Of Common Shares Outstanding Denominator For Basic Ep Sin Shares WeightedAverageOfCommonSharesOutstandingDenominatorForBasicEPSinShares	28923393	shares
CY2022Q2	fpay	Weighted Average Of Common Shares Outstanding Denominator For Basic Ep Sin Shares WeightedAverageOfCommonSharesOutstandingDenominatorForBasicEPSinShares	21605234	shares
CY2022Q2	fpay	Series2 Convertible Preferred Stockin Shares Series2ConvertiblePreferredStockinShares	5845695	shares
CY2022Q2	fpay	Series1 Convertible Preferred Stockin Shares Series1ConvertiblePreferredStockinShares	225231	shares
CY2022Q2	fpay	Common Stock Options And Performance Share Unitsin Shares CommonStockOptionsAndPerformanceShareUnitsinShares	222664	shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	28923393	shares
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	27898824	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.63
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.51
	us-gaap	Operating Lease Payments OperatingLeasePayments	206736	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	200714	usd
	fpay	Finance Lease Principal Payment FinanceLeasePrincipalPayment	4782	usd
	fpay	Finance Lease Principal Payment FinanceLeasePrincipalPayment	5592	usd
CY2023Q2	us-gaap	Fair Value Option Loans Held As Assets90 Days Or More Past Due Aggregate Difference FairValueOptionLoansHeldAsAssets90DaysOrMorePastDueAggregateDifference	15308976	usd
CY2022Q4	us-gaap	Fair Value Option Loans Held As Assets90 Days Or More Past Due Aggregate Difference FairValueOptionLoansHeldAsAssets90DaysOrMorePastDueAggregateDifference	7147585	usd
CY2023Q2	us-gaap	Fair Value Option Loans Held As Assets Aggregate Amount In Nonaccrual Status Aggregated Difference FairValueOptionLoansHeldAsAssetsAggregateAmountInNonaccrualStatusAggregatedDifference	37950094	usd
CY2022Q4	us-gaap	Fair Value Option Loans Held As Assets Aggregate Amount In Nonaccrual Status Aggregated Difference FairValueOptionLoansHeldAsAssetsAggregateAmountInNonaccrualStatusAggregatedDifference	19834547	usd
CY2023Q2	us-gaap	Fair Value Option Loans Held As Assets Aggregate Difference FairValueOptionLoansHeldAsAssetsAggregateDifference	15159360	usd
CY2022Q4	us-gaap	Fair Value Option Loans Held As Assets Aggregate Difference FairValueOptionLoansHeldAsAssetsAggregateDifference	6947224	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2370418	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1000555	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1848129	usd
	fpay	Largest Benefit Percentage LargestBenefitPercentage	0.50	pure
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reclassifications</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior year/period balances have been reclassified to conform with the current year/period presentation. These reclassifications primarily include separating the prepaid expenses, right of use asset and loan revenues and fees, net of changes in fair value as separate line items. </p>
CY2019Q1	fpay	Term Of Lease TermOfLease	P108M
CY2019Q1	fpay	Additional Lease Term AdditionalLeaseTerm	five-year
CY2019Q1	us-gaap	Area Of Land AreaOfLand	21622	sqm
CY2019Q1	fpay	Conversion Of Stock Options Into Common Stock ConversionOfStockOptionsIntoCommonStock	31500	usd
CY2021Q3	us-gaap	Payments For Rent PaymentsForRent	8800	usd
	fpay	Operating Leases Rent Expense Monthly Rent OperatingLeasesRentExpenseMonthlyRent	1700	usd
CY2023Q2	fpay	Total Lease Assets TotalLeaseAssets	1324952	usd
CY2022Q4	fpay	Total Lease Assets TotalLeaseAssets	1406270	usd
CY2023Q2	fpay	Total Lease Liabilities TotalLeaseLiabilities	1676146	usd
CY2022Q4	fpay	Total Lease Liabilities TotalLeaseLiabilities	1774623	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	97367	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	194623	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	97442	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	194697	usd
CY2023Q2	fpay	Operating Lease Future Minimum Payments Due Current OperatingLeaseFutureMinimumPaymentsDueCurrent	210870	usd
CY2023Q2	fpay	Operating Lease Future Minimum Payments Due In Two Years OperatingLeaseFutureMinimumPaymentsDueInTwoYears	430134	usd
CY2023Q2	fpay	Operating Lease Future Minimum Payments Due In Three Years OperatingLeaseFutureMinimumPaymentsDueInThreeYears	443038	usd
CY2023Q2	fpay	Operating Lease Future Minimum Payments Due In Four Years OperatingLeaseFutureMinimumPaymentsDueInFourYears	456330	usd
CY2023Q2	fpay	Operating Lease Future Minimum Payments Due In Five Years OperatingLeaseFutureMinimumPaymentsDueInFiveYears	470019	usd
CY2023Q2	fpay	Operating Lease Future Minimum Payments Due Thereafter OperatingLeaseFutureMinimumPaymentsDueThereafter	303574	usd
CY2023Q2	fpay	Operating Lease Future Minimum Payments Due OperatingLeaseFutureMinimumPaymentsDue	2313965	usd
CY2023Q2	fpay	Interest Interest	-646739	usd
CY2023Q2	fpay	Present Value Of Lease Liabilities PresentValueOfLeaseLiabilities	1667226	usd
	fpay	Schedule Of Undiscounted Finance Lease Liabilities ScheduleOfUndiscountedFinanceLeaseLiabilities	Below is a summary of undiscounted finance lease liabilities as of June 30, 2023<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left; font-size: 10pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Finance<br/> Leases</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 88%; text-align: left">2023</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">4,782</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">4,782</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total undiscounted cash flows</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9,564</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Less: interest</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(644</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 4pt">Present value of lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 4pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">8,920</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4pt; text-align: left"> </td></tr> </table>
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	4782	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	4782	usd
CY2023Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	9564	usd
	fpay	Finance Leaseinterest FinanceLeaseinterest	644	usd
CY2023Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	8920	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	27724562	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	24610028	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	18893584	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16523166	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8830978	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8086862	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1207069	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15338654	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1062423	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	14276231	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15338654	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-176305	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15162349	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	884926	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	1769160	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	1764026	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	1707552	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	1675012	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7800676	usd
	fpay	Principal Accrued Unpaid Interestoutstanding PrincipalAccruedUnpaidInterestoutstanding	1017685	usd
CY2022	fpay	Principal Accrued Unpaid Interestoutstanding PrincipalAccruedUnpaidInterestoutstanding	1017826	usd
CY2023Q2	us-gaap	Interest Expense Other InterestExpenseOther	53346	usd
	us-gaap	Interest Expense Other InterestExpenseOther	105988	usd
CY2022Q2	us-gaap	Interest Expense Other InterestExpenseOther	69428	usd
	us-gaap	Interest Expense Other InterestExpenseOther	102144	usd
CY2023Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	53346	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	105022	usd
CY2022Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	42462	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	104991	usd
	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	917581	usd
CY2021Q1	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	237000	usd
CY2022Q3	fpay	Loans Percentage LoansPercentage	1	pure
CY2022Q3	fpay	Loans Percentage LoansPercentage	1	pure
	fpay	Total Stockbased Compensation TotalStockbasedCompensation	864548	usd
CY2022Q2	fpay	Total Stockbased Compensation TotalStockbasedCompensation	257476	usd
	fpay	Schedule Of Covenant Requirements And Flexshoppers Actual Results ScheduleOfCovenantRequirementsAndFlexshoppersActualResults	A summary of the covenant requirements, and FlexShopper’s actual results at June 30, 2023, follows:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">June 30, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 10pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Required<br/> Covenant</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Actual <br/> Position</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 76%; text-align: left">Equity Book Value not less than</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">16,452,246</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right">27,290,117</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Liquidity greater than</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,500,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6,372,699</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Cash greater than</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">500,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6,378,984</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Consolidated Total Debt to Equity Book Value ratio not to exceed</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5.25</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3.80</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table>
CY2023Q2	fpay	Borrowed Credit Agreement BorrowedCreditAgreement	0	usd
	fpay	Borrowed Credit Agreement BorrowedCreditAgreement	2750000	usd
CY2022Q2	fpay	Borrowed Credit Agreement BorrowedCreditAgreement	11000000	usd
	fpay	Borrowed Credit Agreement BorrowedCreditAgreement	17800000	usd
CY2023Q2	fpay	Repaid Credit Agreement RepaidCreditAgreement	220000	usd
	fpay	Repaid Credit Agreement RepaidCreditAgreement	2795000	usd
CY2022Q2	fpay	Repaid Credit Agreement RepaidCreditAgreement	0	usd
	fpay	Repaid Credit Agreement RepaidCreditAgreement	1125000	usd
CY2022Q2	fpay	Interest Expenses InterestExpenses	1896146	usd
	fpay	Interest Expenses InterestExpenses	3447990	usd
	fpay	Credit Agreement Interest Rate CreditAgreementInterestRate	0.04	pure
	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	225231	shares
	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	1250
	fpay	Warrants Expiration Period WarrantsExpirationPeriod	P7Y
CY2023Q2	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	917581	usd
	fpay	Expense Related To Warrants ExpenseRelatedToWarrants	917581	usd
	fpay	Expense Related To Warrants ExpenseRelatedToWarrants	917581	usd
CY2023Q2	fpay	Expense Related To Warrants ExpenseRelatedToWarrants	0	usd
CY2022Q2	fpay	Expense Related To Warrants ExpenseRelatedToWarrants	0	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2255184	shares
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	443800	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	257476	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	864548	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	562705	usd
CY2023Q2	fpay	Total Stockbased Compensation TotalStockbasedCompensation	443800	usd
	fpay	Total Stockbased Compensation TotalStockbasedCompensation	562705	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1441170	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y2M26D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3919228	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.97
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	52223	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1517844	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.79
	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted	75	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1500	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.79
	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedIntrinsicValue	345	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5435572	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.64
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y3M7D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1102624	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	4049004	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.84
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P6Y7M28D
CY2023Q2	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Aggregate Intrinsic Value1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableAggregateIntrinsicValue1	580962	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3080904	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.06
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1923642	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1050468	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.48
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	162956	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.84
	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedIntrinsicValue	204030	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	7333	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.22
CY2022Q2	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedIntrinsicValue	2273	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	25000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.7
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3936083	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.96
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y2M1D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	39412	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2707122	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.06
	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P6Y6M29D
CY2022Q2	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Aggregate Intrinsic Value1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableAggregateIntrinsicValue1	39412	usd
	fpay	Weighted Average Grant Fair Value WeightedAverageGrantFairValue	0.6
	fpay	Weighted Average Grant Fair Value WeightedAverageGrantFairValue	0.89
CY2022Q4	fpay	Share Based Compensation Arrangement By Shares Based Payment Award Options Vested And Expected To Vest Outstanding Number1 ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber1	790327	shares
CY2022Q4	fpay	Share Based Compensation Arrangement By Shares Based Payments Award Options Vested And Expected To Vest Outstanding Number1 ShareBasedCompensationArrangementBySharesBasedPaymentsAwardOptionsVestedAndExpectedToVestOutstandingNumber1	1.53	shares
	fpay	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod1	1250000	shares
	fpay	Weighted Average Grant Date Fair Value Granted Shares WeightedAverageGrantDateFairValueGrantedShares	0.78	shares
	fpay	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod1	-790327	shares
	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod1	1.53	shares
CY2023Q2	fpay	Share Based Compensation Arrangement By Shares Based Payment Award Options Vested And Expected To Vest Outstanding Number1 ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber1	1250000	shares
CY2023Q2	fpay	Share Based Compensation Arrangement By Shares Based Payments Award Options Vested And Expected To Vest Outstanding Number1 ShareBasedCompensationArrangementBySharesBasedPaymentsAwardOptionsVestedAndExpectedToVestOutstandingNumber1	0.78	shares
	fpay	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod1	790327	shares
	fpay	Weighted Average Grant Date Fair Value Granted Shares WeightedAverageGrantDateFairValueGrantedShares	1.53	shares
CY2022Q2	fpay	Share Based Compensation Arrangement By Shares Based Payment Award Options Vested And Expected To Vest Outstanding Number1 ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber1	790327	shares
CY2022Q2	fpay	Share Based Compensation Arrangement By Shares Based Payments Award Options Vested And Expected To Vest Outstanding Number1 ShareBasedCompensationArrangementBySharesBasedPaymentsAwardOptionsVestedAndExpectedToVestOutstandingNumber1	1.53	shares
CY2023Q2	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.22	pure
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod1		shares
	fpay	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod1		shares
	fpay	Share Based Compensation Arrangement By Share Based Payments Award Equity Instruments Other Than Options Vested In Period1 ShareBasedCompensationArrangementByShareBasedPaymentsAwardEquityInstrumentsOtherThanOptionsVestedInPeriod1		shares
CY2023Q2	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	2000000	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001397047
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>12. CONTINGENCIES AND OTHER UNCERTAINTIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Regulatory inquiries</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the first quarter of 2021, FlexShopper, along with a number of other lease-to-own companies, received a subpoena from the California Department of Financial Protection and Innovation (the “DFPI”) requesting the production of documents and information regarding the Company’s compliance with state consumer protection laws. The Company is cooperatively engaging with the DFPI in response to its inquiry. Although the Company believes it is in compliance with all applicable consumer protection laws and regulations in California, this inquiry ultimately could lead to an enforcement action and/or a consent order, and substantial costs, including legal fees, fines, penalties, and remediation expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Litigation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is not involved in any current or pending material litigation. The Company could be involved in litigation incidental to the operation of the business. The Company intends to vigorously defend all matters in which the Company is named defendants, and, for insurable losses, maintain significant levels of insurance to protect against adverse judgments, claims or assessments that may affect the Company. Although the adequacy of existing insurance coverage of the outcome of any legal proceedings cannot be predicted with certainty, based on the current information available, the Company does not believe the ultimate liability associated with known claims or litigation, if any, in which the Company is involved will materially affect the Company’s consolidated financial condition or results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Employment agreements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain executive management entered into employment agreements with the Company. The contracts are for a period between three to five years and renew for three successive one-year terms unless receipt of written notices by the parties. The contracts provide that such management may earn discretionary cash bonuses and equity awards, based on financial performance metrics defined each year by the Compensation Committee of the Company’s Board of Directors. Additionally, under certain termination conditions, such contracts provide for severance payments and other benefits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>COVID-19 and other similar health crisis</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has been, and may in the future, be impacted by COVID-19 or any similar pandemic or health crisis, and this could affect our results of operations, financial condition, or cash flow in the future. The extent and the effects of the impact of any of these events on the operation and financial performance of our business depend on several factors which are highly uncertain and cannot be predicted.</p>
	fpay	Principal Amounts PrincipalAmounts	5000000	usd
CY2023Q2	us-gaap	Investment Maturity Date InvestmentMaturityDate	2027-12-01
	fpay	Interest Per Annum InterestPerAnnum	0.08	pure
	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	3421991	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	3133617	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	3158471	usd
	fpay	Business Combination Bargain Price BusinessCombinationBargainPrice	14461274	usd
	us-gaap	Gain Loss On Sales Of Consumer Loans GainLossOnSalesOfConsumerLoans	20000000	usd
CY2023Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.1342	pure
	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.10	pure
CY2023Q2	us-gaap	Interest Expense Interest Bearing Liability InterestExpenseInterestBearingLiability	289574	usd
	us-gaap	Interest Expense Interest Bearing Liability InterestExpenseInterestBearingLiability	592014	usd
CY2023Q2	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	7412605	usd
CY2023Q2	fpay	Unamortized Debt Issuances Expense UnamortizedDebtIssuancesExpense	112197	usd
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.04	pure
CY2023Q2	us-gaap	Defined Benefit Plan Plan Assets Contributions By Plan Participant DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant	36	usd
	us-gaap	Defined Benefit Plan Plan Assets Contributions By Plan Participant DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant	86762	usd
CY2022Q2	us-gaap	Defined Benefit Plan Plan Assets Contributions By Plan Participant DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant	30756	usd
	us-gaap	Defined Benefit Plan Plan Assets Contributions By Plan Participant DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant	81373	usd
CY2023Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	2000000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	fpay	Interest In Kind Added To Promissory Notes Balance InterestInKindAddedToPromissoryNotesBalance		usd
	fpay	Purchase Consideration Payable Related To Acquisition PurchaseConsiderationPayableRelatedToAcquisition		usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
	fpay	Proceeds From Debt Instrument ProceedsFromDebtInstrument		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt		usd
	fpay	Due Date Extension Of Warrants DueDateExtensionOfWarrants		usd
	fpay	Net Income Attributable To Series1 Convertible Preferred Stock NetIncomeAttributableToSeries1ConvertiblePreferredStock		usd
	fpay	Convertible Preferred Stock Dividends ConvertiblePreferredStockDividends		usd
	fpay	Series2 Convertible Preferred Stockin Shares Series2ConvertiblePreferredStockinShares		shares
	fpay	Series1 Convertible Preferred Stockin Shares Series1ConvertiblePreferredStockinShares		shares
	fpay	Common Stock Options And Performance Share Unitsin Shares CommonStockOptionsAndPerformanceShareUnitsinShares		shares
	fpay	Common Stock Warrants CommonStockWarrants		shares
CY2023Q2	fpay	Net Income Attributable To Series1 Convertible Preferred Stock NetIncomeAttributableToSeries1ConvertiblePreferredStock		usd
CY2023Q2	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments		usd
CY2023Q2	fpay	Convertible Preferred Stock Dividends ConvertiblePreferredStockDividends		usd
CY2023Q2	fpay	Series2 Convertible Preferred Stockin Shares Series2ConvertiblePreferredStockinShares		shares
CY2023Q2	fpay	Series1 Convertible Preferred Stockin Shares Series1ConvertiblePreferredStockinShares		shares
CY2023Q2	fpay	Common Stock Options And Performance Share Unitsin Shares CommonStockOptionsAndPerformanceShareUnitsinShares		shares
CY2023Q2	fpay	Common Stock Warrants CommonStockWarrants		shares
CY2022Q2	fpay	Common Stock Warrants CommonStockWarrants		shares
	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted		usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
	fpay	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod1		shares
	fpay	Share Based Compensation Arrangement By Share Based Payments Award Equity Instruments Other Than Options Vested In Period1 ShareBasedCompensationArrangementByShareBasedPaymentsAwardEquityInstrumentsOtherThanOptionsVestedInPeriod1		shares
CY2021Q4	fpay	Share Based Compensation Arrangement By Shares Based Payment Award Options Vested And Expected To Vest Outstanding Number1 ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber1		shares
CY2021Q4	fpay	Share Based Compensation Arrangement By Shares Based Payments Award Options Vested And Expected To Vest Outstanding Number1 ShareBasedCompensationArrangementBySharesBasedPaymentsAwardOptionsVestedAndExpectedToVestOutstandingNumber1		shares
	fpay	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod1		shares

Files In Submission

Name	View Source	Status
0001213900-23-066993-index-headers.html	Edgar Link	pending
0001213900-23-066993-index.html	Edgar Link	pending
0001213900-23-066993.txt	Edgar Link	pending
0001213900-23-066993-xbrl.zip	Edgar Link	pending
f10q0623ex31-1_flexshopper.htm	Edgar Link	pending
f10q0623ex32-1_flexshopper.htm	Edgar Link	pending
f10q0623_flexshopper.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fpay-20230630.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
fpay-20230630_cal.xml	Edgar Link	unprocessable
fpay-20230630_def.xml	Edgar Link	unprocessable
fpay-20230630_lab.xml	Edgar Link	unprocessable
fpay-20230630_pre.xml	Edgar Link	unprocessable
f10q0623_flexshopper_htm.xml	Edgar Link	completed
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FPAY
FlexShopper, Inc. Stock $fpay

2023 Q3 Form 10-Q Financial Statement

#000121390023066993 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FPAY FlexShopper, Inc. Stock $fpay

2023 Q3 Form 10-Q Financial Statement

#000121390023066993 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FPAY
FlexShopper, Inc. Stock $fpay